Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.

Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB.

Sci Rep. 2019 Apr 16;9(1):6161. doi: 10.1038/s41598-019-42450-0.

2.

Should wrong extraction site be classed as a never event?

Sampson V.

Br Dent J. 2018 Aug 24;225(4):291-292. doi: 10.1038/sj.bdj.2018.649. Epub 2018 Aug 17.

PMID:
30117499
3.

Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.

Mills CC, Kolb EA, Sampson VB.

Cancer Res. 2018 Jan 15;78(2):320-325. doi: 10.1158/0008-5472.CAN-17-2782. Epub 2018 Jan 8. Review.

4.

Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer.

Mills CC, Kolb EA, Sampson VB.

Cancer Res. 2017 Dec 1;77(23):6489-6498. doi: 10.1158/0008-5472.CAN-17-2066. Epub 2017 Nov 2. Review.

5.

Unilateral Atraumatic Expulsion of an Ectopic Pregnancy in a Case of Bilateral Ectopic Pregnancy.

Sampson V, Mogekwu O, Ahmed A, Bano F.

Case Rep Obstet Gynecol. 2017;2017:6391849. doi: 10.1155/2017/6391849. Epub 2017 Sep 27.

6.

The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/╬▓III-Tubulin Axis.

Vetter NS, Kolb EA, Mills CC, Sampson VB.

Mol Cancer Res. 2017 Jul;15(7):953-964. doi: 10.1158/1541-7786.MCR-16-0372. Epub 2017 Mar 8.

7.

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.

Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA.

Oncotarget. 2016 Dec 27;7(52):86594-86607. doi: 10.18632/oncotarget.13358.

8.

Simulating the slow to fast switch in cytochrome c oxidase catalysis by introducing a loop flip near the enzyme's cytochrome c (substrate) binding site.

Alleyne T, Ignacio DN, Sampson VB, Ashe D, Wilson M.

Biotechnol Appl Biochem. 2017 Sep;64(5):677-685. doi: 10.1002/bab.1526. Epub 2017 Jun 7.

PMID:
27489224
9.

Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.

Sampson VB, Vetter NS, Kamara DF, Collier AB, Gresh RC, Kolb EA.

PLoS One. 2015 Nov 16;10(11):e0142704. doi: 10.1371/journal.pone.0142704. eCollection 2015.

10.

MicroRNAs and Potential Targets in Osteosarcoma: Review.

Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA.

Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015. Review.

11.

A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.

Kolb EA, Sampson V, Stabley D, Walter A, Sol-Church K, Cripe T, Hingorani P, Ahern CH, Weigel BJ, Zwiebel J, Blaney SM.

Pediatr Blood Cancer. 2015 May;62(5):751-8. doi: 10.1002/pbc.25464. Epub 2015 Feb 27.

12.

Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.

Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV, Rajasekaran AK.

PLoS One. 2014 Jul 15;9(7):e102041. doi: 10.1371/journal.pone.0102041. eCollection 2014.

13.

Oncolytic viruses for potential osteosarcoma therapy.

Hingorani P, Sampson V, Lettieri C, Kolb EA.

Adv Exp Med Biol. 2014;804:259-83. doi: 10.1007/978-3-319-04843-7_14. Review.

PMID:
24924179
14.

Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.

Sampson VB, Kamara DF, Kolb EA.

Expert Opin Drug Discov. 2013 Oct;8(10):1181-9. doi: 10.1517/17460441.2013.817988. Epub 2013 Jul 12. Review.

15.

A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma.

Sampson VB, Gorlick R, Kamara D, Anders Kolb E.

Front Oncol. 2013 May 31;3:132. doi: 10.3389/fonc.2013.00132. eCollection 2013.

16.

Substrate binding-dissociation and intermolecular electron transfer in cytochrome c oxidase are driven by energy-dependent conformational changes in the enzyme and substrate.

Ashe D, Alleyne T, Sampson V.

Biotechnol Appl Biochem. 2012 May-Jun;59(3):213-22. doi: 10.1002/bab.1015. Epub 2012 May 9.

PMID:
23586831
17.

The efficacy of student-centered instruction in supporting science learning.

Granger EM, Bevis TH, Saka Y, Southerland SA, Sampson V, Tate RL.

Science. 2012 Oct 5;338(6103):105-8. doi: 10.1126/science.1223709.

18.

Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer.

Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK.

Am J Physiol Lung Cell Mol Physiol. 2012 Jun 1;302(11):L1150-8. doi: 10.1152/ajplung.00384.2010. Epub 2012 Feb 17.

19.

Early electron transfer in cytochrome c oxidase occurs by a chymotrypsin type relay.

Alleyne T, Sampson VB.

West Indian Med J. 2009 Dec;58(6):499-505.

PMID:
20583674
20.

Probing the specifics of substrate binding for cytochrome c oxidase: a computer assisted approach.

Sampson VB, Alleyne T, Ashe D.

West Indian Med J. 2009 Jan;58(1):54-60.

PMID:
19565999
21.

Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.

Tummala R, Wolle D, Barwe SP, Sampson VB, Rajasekaran AK, Pendyala L.

Cancer Chemother Pharmacol. 2009 Nov;64(6):1187-94. doi: 10.1007/s00280-009-0985-x. Epub 2009 Mar 26.

22.

Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.

Sampson VB, Dunn SP, Rymeski B, Malatack J, Rong NH, Flynn L, Krueger LJ.

J Pediatr Surg. 2008 Jun;43(6):1134-41. doi: 10.1016/j.jpedsurg.2008.02.044.

PMID:
18558196
23.

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.

Cancer Res. 2007 Oct 15;67(20):9762-70.

24.

Cyclic AMP regulates the expression and nuclear translocation of RFC40 in MCF7 cells.

Gupte RS, Sampson V, Traganos F, Darzynkiewicz Z, Lee MY.

Exp Cell Res. 2006 Apr 1;312(6):796-806. Epub 2006 Jan 17.

PMID:
16413017
26.

Cytochrome-c detection: a diagnostic marker for myocardial infarction.

Alleyne T, Joseph J, Sampson V.

Appl Biochem Biotechnol. 2001 Feb;90(2):97-105.

PMID:
11297391
27.

Cytochrome-c oxidase isolated from the brain of swayback-diseased sheep displays unusual structure and uncharacteristic kinetics.

Alleyne T, Joseph J, Lalla A, Sampson V, Adogwa A.

Mol Chem Neuropathol. 1998 Jun-Aug;34(2-3):233-47.

PMID:
10327420
28.

Identification and characterization of a recombinant metallothionein protein from a marine alga, Fucus vesiculosus.

Morris CA, Nicolaus B, Sampson V, Harwood JL, Kille P.

Biochem J. 1999 Mar 1;338 ( Pt 2):553-60.

30.

Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology.

Vickers JC, Chin D, Edwards AM, Sampson V, Harper C, Morrison J.

Exp Neurol. 1996 Sep;141(1):1-11.

PMID:
8797662
31.

Intensive quit smoking program in a dental setting using nicotine gum: one year results.

Christen AG, Olson BL, Sampson VM, McDonald JL Jr.

CDA J. 1986 Nov;14(11):28-34. No abstract available.

PMID:
3465456
32.

Dental family stress and coping patterns.

Nevin RS, Sampson VM.

Dent Clin North Am. 1986 Oct;30(4 Suppl):S117-32.

PMID:
3465636
33.

The Tokelau Island Migrant Study: serum lipid concentration in two environments.

Stanhope JM, Sampson VM, Prior IA.

J Chronic Dis. 1981;34(2-3):45-55. No abstract available.

PMID:
7462380
34.

High density lipoprotein cholesterol and other serum lipids in New Zealand Maoris.

Beaglehole R, Prior IA, Eyles E, Sampson V.

N Z Med J. 1979 Aug 22;90(642):139-42.

PMID:
226914
36.

Bilateral loss of vision complicating mitral stenosis.

HOCKIN RL, SAMPSON VE, SUTHERLAND JM.

Med J Aust. 1959 Aug 8;46(2):185-7. No abstract available.

PMID:
14402212
37.

Nephrocalcinosis.

SAMPSON V.

Med J Aust. 1957 Apr 13;44(15):504-6. No abstract available.

PMID:
13430045

Supplemental Content

Loading ...
Support Center